<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03073330</url>
  </required_header>
  <id_info>
    <org_study_id>8550</org_study_id>
    <nct_id>NCT03073330</nct_id>
  </id_info>
  <brief_title>One Step Versus Two Step Approach for Gestational Diabetes Mellitus Screening</brief_title>
  <acronym>OTSAS</acronym>
  <official_title>One vs Two Step Approach for GDM Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study will assess if there is a difference in incidence of gestational diabetes using
      different screening approaches, either using a one-step approach with a 2 hour glucose
      tolerance test or using a two-step approach. Prior studies have proven similar incidences
      including a randomized controlled trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gestational Diabetes is screened for in pregnancy by drinking a solution containing a certain
      amount of glucose and testing blood glucose level one hour after drinking it. If this value
      is above a certain cut-off (&gt;135mg/dl), the patient is subjected to another test involving
      drinking a solution containing a higher amount of glucose and checking blood glucose while
      fasting, 1 hour after drinking the solution and 2 hours after drinking the solution. (Two
      step approach).

      Cut off values will be: 3 hour&gt;180 mg/dl, 2 hour &gt; 155 mg/dl, 1hour &gt;140 mg/dl, fasting
      &gt;95mg/dl. Two abnormal values will meet the diagnosis of gestational diabetes.

      In other parts of the United States, and most of the rest of the word, screening for
      gestational diabetes uses a one-step approach by drinking a solution containing 75g of
      glucose (As recommended by the American Diabetic Society, the Endocrine Society, WHO and the
      International Association of Diabetes and Pregnancy Study groups1-3). Blood glucose values
      are checked at fasting, one hour and two hours after solution drinking.

      The diagnosis of gestational diabetes is based on one elevated values. (cut off: Fasting
      ≥92mg/dl, 1hour ≥180 mg/dl, 2 hours ≥153 mg/dl).

      Our study will assess if there is a difference in incidence of gestational diabetes using
      these different screening approaches. Prior studies have proven similar incidences including
      a randomized controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of gestational diabetes diagnosed on each screening test of each arm.</measure>
    <time_frame>at the time of the screening</time_frame>
    <description>Gestational diabetes will be made based on one abnormal value. Fasting ≥126 mg/dl; 1 hour≥ 180 mg/dl and 2 hour ≥ 153 mg/dl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>neonatal hyperbilirubinemia</measure>
    <time_frame>first 48 hours of life</time_frame>
    <description>incidence of neonatal hyperbilirubinemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mode of delivery</measure>
    <time_frame>at time of delivery</time_frame>
    <description>incidence of cesarean delivery, spontaneous vaginal delivery, operative vaginal delivery, and induction of labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gestational age at delivery</measure>
    <time_frame>at time of delivery</time_frame>
    <description>gestational age at delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anal sphincter injury</measure>
    <time_frame>at time of delivery</time_frame>
    <description>Incidence of Anal sphincter injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shoulder dystocia</measure>
    <time_frame>at time of delivery</time_frame>
    <description>incidence of shoulder dystocia, and birth trauma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal complications</measure>
    <time_frame>between birth and 28 days of age</time_frame>
    <description>includes necrotizing enterocolitis, respiratory distress syndrome, intraventricular hemorrhage, hypoglycemia, jaundice, hyperbilirubinemia, perinatal death, admission to neonatal intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypertensive disorders in pregnancy</measure>
    <time_frame>6 months</time_frame>
    <description>includes gestational hypertension, preeclampsia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal growth restriction, large for gestational age and polyhydramnios</measure>
    <time_frame>6 months</time_frame>
    <description>Incidence of Fetal growth restriction,large for gestational age and polyhydramnios</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth weight</measure>
    <time_frame>Time of delivery</time_frame>
    <description>Mean of birth weight and incidence of macrosomia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar score</measure>
    <time_frame>at 1, 5 and 10 minutes after birth</time_frame>
    <description>Apgar score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">284</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>One Step</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention is gestational diabetes screening with 2 hour GTT 75 g load.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two Step</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>There is no intervention is this arm as patients will subjected to routine gestational diabetes screening with one hour glucola, 50 g load.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>GDM screening with 75 g 2 hour GTT</intervention_name>
    <description>Patients will be diagnosed with gestational diabetes if they have one abnormal value: Fasting ≥ 92; 2 hour ≥ 180 mg/dl;1 hour ≥ 153 mg/dl.</description>
    <arm_group_label>One Step</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>GDM screening with two step approach</intervention_name>
    <description>1 hour glucola with 50 g glucose load followed by 100 g glucose load if 1 hour glucola positive</description>
    <arm_group_label>Two Step</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  16-50 year of age

          -  Pregnant women (limits the participants to female gender)

        Exclusion Criteria:

          -  Pregestational Diabetes Mellitus

          -  History of bariatric surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women (limits the participants to female gender)</gender_description>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adeeb Khalifeh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adeeb Khalifeh, MD</last_name>
    <email>adeeb.khalifeh@jefferson.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adeeb Khalifeh, MD</last_name>
      <email>adeeb.khalifeh@jefferson.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Southwick AM, Wang LX, Long SR, Lee YC. Activity of Sinorhizobium meliloti NodAB and NodH enzymes on thiochitooligosaccharides. J Bacteriol. 2002 Jul;184(14):4039-43.</citation>
    <PMID>12081977</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thomas Jefferson University</investigator_affiliation>
    <investigator_full_name>adeeb khalifeh</investigator_full_name>
    <investigator_title>Physician Fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

